S evere bone deficiency is a major challenge in acetabular revision surgery. At one time, reconstructing the acetabulum with cement and a reinforcing device to the native bone was a popular treatment option. This procedure, however, was ultimately abandoned due to poor results at medium or long-term followup [1, 12, 13] . The use of threaded, oversized-threaded, oblong, or ''jumbo'' cups likewise failed to yield good results at long-term followup [7, 9, 10] . While some studies [6, 8, 11] maintain that massive bulk allograft remain an option, slow resorption and substitution by native bone (creeping substitution) takes place only on the surface of the allograft, and perhaps because of this, in the long-term, the failure rate of this approach can be high.
By contrast, one technique that seems to have stood the test of time is impaction bone grafting (IBG). This approach appears to stimulate bone regeneration, neovascularization, and predictable creeping substitution; support for this approach includes experimental studies in animals, imaging studies (conventional radiographic followup, PET-TAC), biopsies in retrievals, and clinical and radiographic followup reports out to 25 years. [2] [3] [4] [5] .
Where Do We Need To Go?
Those of us who practice IBG for acetabular defects find that it succeeds in most patients who receive it. However, some studies report failures, including catastrophic failures [14] , and so we should further define the contraindications for IBG. The study by Garcia-Rey and colleagues establishes differences in long-term results according to the type of defect and use of lateral mesh. But some points are not clearly defined, and future studies should focus on these. The influence of sex, including sex-related differences in bone quality and/or activity, the relationship of prior surgery (both type and number) on the results of this procedure, and the size of allograft fragments used all must be studied further.
Garcia-Rey and colleagues did a good job of analyzing by the extent of the bone defect; type 2, 3A, 3B, and pelvic discontinuities each represent different reconstructive problems. Future studies should likewise be large enough to stratify results according to the type and severity of the bone defects being treated. While IBG is generally well-behaved, we do need to pay particular attention to those situations in which it does not work well. We must also look for alternatives in those settings, perhaps including porous metal augments. Comparisons between IBG and these implants may represent a good topic for future investigations.
How Do We Get There?
We should begin obtaining long-term results of porous metal augments, which have been on the market for more than 10 years. Many surgeons use them, but we still need high-quality papers analyzing their long-term results.
In particular, studies on this topic must stratify results according to the type of defect. Clearly, studies will evaluate the results of metallic augments for contained defects, but now we know that IBG is a good solution for this problem. What we need to know is whether metallic augments can improve long-term results in 3B/lateral/segmental defects, which are difficult to treat. We also might consider evaluating the combination of porous metal augments with IBG. Finally, we must perform more prospective comparative, and ideally, randomized studies examining IBG versus metal augments, as well as the results of IBG with and without these augments.
